Lakefront Biotherapeutics | GLPG - Passivo Circulante





Passivo Circulante Alterar Data
argenx SE USD 1.32B 278.28M 2025-12
AstraZeneca USD 32.57B 1.95B 2026-03
Biogen USD 3B 350.5M 2026-03
Genmab DKK 1.43B 686M 2025-12
Gilead Sciences USD 9.48B 2.34B 2026-03
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
GRIFOLS EUR 2.12B 105M 2026-03
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Incyte USD 1.49B 25.52M 2026-03
Merck EUR 9.35B 307M 2026-03
Neurocrine Biosciences USD 831.7M 88.3M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 30.01B 1.66B 2026-03
UCB EUR 4.4B 470M 2025-12
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03